Target intelligence / Profile preview

Porcine epidemic diarrhea virus spike protein subunit 1 (PEDV-S1)

Target
PEDV-S1
Molecular classification
Viral surface protein, Type I transmembrane protein, Class I viral fusion protein subunit
01

Overview

The Porcine epidemic diarrhea virus spike protein subunit 1 (PEDV-S1) is the N-terminal subunit of the large spike glycoprotein, playing a fundamental role in the initial stages of viral pathogenesis. It contains the receptor-binding domain (RBD) and multiple neutralizing epitopes, making it the primary target for host immune responses and vaccine development (Li et al., 2016, Journal of Virology). The S1 subunit facilitates viral attachment by binding to host cell receptors, including porcine aminopeptidase N (pAPN) and various sialic acid residues, which triggers the subsequent membrane fusion mediated by the S2 subunit (Nam & Lee, 2021, Viruses). In the field, PEDV-S1 is the driver of Porcine Epidemic Diarrhea, a disease causing high mortality in neonatal piglets due to severe malabsorptive diarrhea and dehydration. From a therapeutic perspective, most recombinant vaccines and neutralizing antibodies are designed to target the S1 region to prevent viral entry. However, significant genetic diversity and frequent mutations within the S1 gene lead to the emergence of new strains, posing a challenge for the efficacy of traditional vaccines and the development of universal therapeutic agents (Sun et al., 2018, Vaccine).

Other names
S1 subunit of spike glycoproteinPEDV S1 proteinSpike protein S1 domainPorcine epidemic diarrhea virus S1 glycoprotein
02

Mechanism of action

Neutralization of viral infection by blocking the receptor-binding domain (RBD) within the S1 subunit, preventing the virus from attaching to host receptors such as porcine aminopeptidase N (pAPN) or sialic acids.

03

Biological functions

Viral attachment to host cellReceptor bindingHost cell entryAntigenic recognition
04

Disease associations

InfectionPorcine Epidemic Diarrhea (PED)
05

Safety considerations

Antigenic drift due to high mutation rates in the S1 domainAntibody-dependent enhancement (ADE) of infectionLimited cross-protection between different genogroups (G1 vs G2)Difficulty in maintaining long-term mucosal immunity
06

Interacting drugs

Recombinant PEDV S1 vaccines

3 more in the full profile.

07

Biomarkers

S1-specific serum IgG titersMucosal IgA levelsViral RNA load (via RT-qPCR)S1 protein expression in intestinal villi

Beyond the preview

Go deeper on Porcine epidemic diarrhea virus spike protein subunit 1 (PEDV-S1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Porcine epidemic diarrhea virus spike protein subunit 1 (PEDV-S1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call